Predictive value of changes in the level of carbohydrate antigen 19‐9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

Abstract

Following nCRT, changes in the CA19-9 level are a strong prognostic marker for long-term survival, and they may be helpful in the selection of patients who prefer more conservative surgery after chemoradiotherapy.